Uterus Transplant Feasible, Linked to High Rate of Live Birth
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 19, 2024 -- Uterus transplant is feasible and is associated with high rates of live birth after successful graft survival, according to a study published online Aug. 15 in the Journal of the American Medical Association.
Giuliano Testa, M.D., from Baylor University Medical Center in Dallas, and colleagues examined whether uterus transplant is feasible and results in births of healthy infants in a case series of 20 participants with uterine-factor infertility and at least one functioning ovary. The uterus transplant (18 from living donors and two from deceased donors) was surgically placed in an orthotopic position with vascular anastomoses to the external iliac vessels; immunosuppression was given to recipients until removal of the uterus after one or two live births or graft failure.
The researchers found that 14 of the 20 participants had a successful uterus allograft; all 14 gave birth to at least one live-born infant. Of the 20 recipients, 11 had at least one complication. In 50 percent of the successful pregnancies, maternal and/or obstetric complications occurred, with the most common being gestational hypertension, cervical insufficiency, and preterm labor (14, 14, and 14 percent, respectively). No congenital malformations occurred in the 16 live-born infants. Grade 3 complications occurred in four of 18 living donors.
"During the study period, the technical success of graft survival improved with time and experience," the authors write. "All 14 participants with successful uterus transplant had a subsequent live birth."
Abstract/Full Text (subscription or payment may be required)
Editorial (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2024-08-20 03:15
Read more
- Cutaneous Malignant Melanoma Incidence Increasing Among the Elderly
- 2022 to 2023 Saw No Change in U.S. Infant Mortality Rate
- Psychedelics Like Psilocybin, MDMA Tied to Higher Odds for Schizophrenia
- Leads Biolabs Receives Orphan Drug Designation from the US FDA for LBL-034, a Uniquely Designed, Highly Differentiated Anti-GPRC5D/CD3 Bispecific Antibody, for the Treatment of Multiple Myeloma
- First U.S. Case of New Mpox Strain Spotted in Traveler
- Winter's Onset Brings Mood Changes to Many Americans, Poll Finds
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions